- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nonalcoholic Fatty Liver Disease in United Kingdom
Total 4166 results
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
Madrigal Pharmaceuticals, Inc.CompletedHepatic Impairment | NASH - Nonalcoholic Steatohepatitis | Cirrhosis, LiverUnited States
-
University of California, Los AngelesNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...RecruitingNAFLD | NASH - Nonalcoholic SteatohepatitisUnited States
-
Virginia Commonwealth UniversityWithdrawnObesity | Non-Alcoholic Fatty Liver Disease | Fatty Liver, NonalcoholicUnited States
-
Icahn School of Medicine at Mount SinaiCompletedNonalcoholic Fatty Liver DiseaseUnited States
-
The University of Texas Health Science Center at...National Institutes of Health (NIH); Takeda Pharmaceuticals North America,...CompletedNonalcoholic SteatohepatitisUnited States
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Germany, Argentina
-
Inventiva PharmaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Austria, Belgium, France, Germany, Israel, Portugal, Spain, United Kingdom, Canada, Italy, China, Brazil, Netherlands, Hungary, Bulgaria, Chile, Czechia, Mexico, Poland, Puerto Rico, South Africa, Uk...
-
Washington University School of MedicineCompleted
-
West Virginia UniversityRecruitingNonalcoholic Fatty Liver DiseaseUnited States
-
Akero Therapeutics, IncRecruitingNASH/MASH | NAFLD/MASLDUnited States, Canada, Puerto Rico, Australia, India
-
Washington University School of MedicineCompletedNon-alcoholic Fatty Liver Disease (NAFLD)United States
-
Massachusetts General HospitalCompleted
-
Merck Sharp & Dohme LLCTerminatedNonalcoholic SteatohepatitisKorea, Republic of, United States, Argentina, Australia, Canada, Chile, China, Colombia, France, Germany, Greece, Hong Kong, Israel, Italy, Japan, Malaysia, Mexico, New Zealand, Puerto Rico, Russian Federation, Spain, Sweden, Taiwan, ...
-
Mirum Pharmaceuticals, Inc.TerminatedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, Canada, Puerto Rico
-
Ionis Pharmaceuticals, Inc.CompletedSteatohepatitis, NonalcoholicUnited States, Puerto Rico
-
Boston PharmaceuticalsActive, not recruitingNonalcoholic Steatohepatitis (NASH)United States
-
GenfitTerminatedNonalcoholic Steatohepatitis (NASH) With FibrosisUnited States, Belgium, Germany, France, Canada, Netherlands, Italy, Switzerland, Finland, Puerto Rico, United Kingdom, Denmark, Spain, Australia, Czechia, Sweden, Romania, Argentina, Portugal, Turkey, Mexico, Colombia, South Africa, ... and more
-
Virginia Commonwealth UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingNonalcoholic SteatohepatitisUnited States
-
Hepion Pharmaceuticals, Inc.Active, not recruitingNAFLD | Nonalcoholic Steatohepatitis (NASH) | Fibrosis, LiverUnited States, France, Mexico
-
University of MinnesotaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
University of FloridaInventiva PharmaCompletedNonalcoholic Fatty Liver Disease (NAFLD) | Type 2 Diabetes (T2DM)United States
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedNonalcoholic Steatohepatitis | Lipodystrophy | Fatty Liver Disease, NonalcoholicUnited States
-
Melinta Therapeutics, Inc.CompletedNonalcoholic SteatohepatitisUnited States
-
Forma Therapeutics, Inc.ProSciento, Inc.TerminatedNonalcoholic Steatohepatitis (NASH) | Overweight or ObesityUnited States
-
William Beaumont HospitalsTerminatedFibrosis, Liver | Cirrhosis, Liver | Steatohepatitis, Nonalcoholic | Fatty Liver DiseaseUnited States
-
Galmed Research and Development, Ltd.SuspendedNonalcoholic Steatohepatitis (NASH)United States
-
University of Colorado, DenverRecruiting
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisUnited States, France
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
Nemours Children's ClinicCompletedObesity | Cardiovascular Disease | Nonalcoholic Fatty Liver DiseaseUnited States
-
University of Illinois at ChicagoTerminatedNonalcoholic Steatohepatitis (NASH) | Hepatic SteatosisUnited States
-
Metacrine, Inc.Active, not recruitingDiabetes | Fatty Liver | Type 2 Diabetes | NAFLD | NASH - Nonalcoholic Steatohepatitis | Diabetes Type 2 | NASH | Fatty Liver, NonalcoholicUnited States
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisUnited States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland
-
Duke UniversityUniversity of FloridaTerminatedInsulin Resistance | Nonalcoholic Fatty Liver DiseaseUnited States
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedDiabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, NonalcoholicUnited States, Canada
-
Indiana UniversityRecruitingNASH - Nonalcoholic Steatohepatitis | Cirrhosis, LiverUnited States
-
University of FloridaThe University of Texas at San AntonioCompletedType 2 Diabetes Mellitus | Nonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisHong Kong, United States, Spain, United Kingdom, Australia, Taiwan, Belgium, Canada, India, Japan, Korea, Republic of, Singapore, Puerto Rico, France, Israel, Austria, Germany, Italy, Malaysia, New Zealand, Mexico, Poland, Switzerland, Netherlan... and more
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Primary Sclerosing Cholangitis (PSC)United States, New Zealand
-
National Institute of Diabetes and Digestive and...Completed
-
National Cancer Institute (NCI)RecruitingHepatocellular Carcinoma | Nonalcoholic SteatohepatitisUnited States
-
University of Kansas Medical CenterGilead SciencesRecruiting
-
Indiana University School of MedicineTerminatedHIV Infections | NAFLD | NASH - Nonalcoholic SteatohepatitisUnited States
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisHong Kong, United States, Australia, Puerto Rico, New Zealand, Canada
-
Tobira Therapeutics, Inc.TerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Australia, France, Germany, Spain, Poland, United Kingdom, Italy, Puerto Rico, Belgium, Hong Kong
-
Massachusetts General HospitalActive, not recruitingObesity | Fatty Liver | Liver Fat | Obesity, Abdominal | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Cirius Therapeutics, Inc.Chiltern International Inc.CompletedNon-alcoholic Fatty Liver Disease | NASH - Nonalcoholic Steatohepatitis | Non-alcoholic SteatohepatitisUnited States
-
Altimmune, Inc.RecruitingNon-Alcoholic Steatohepatitis (NASH)Australia, United States, Puerto Rico